한글목차

NGS 기반 RNA 시퀀싱 시장(2024-2028년)

NGS 기반 RNA 시퀀싱 시장은 2023-2028년 간에 20.52%의 CAGR로 성장하며, 66억 5,900만 달러에까지 확대할 것으로 예측됩니다. 이 조사 리포트는 NGS 기반 RNA 시퀀싱 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인·과제, 약 25사의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 차세대 시퀀싱 방법의 채택 증가, 시퀀싱 플랫폼의 기술 진보, 폭넓은 차세대 시퀀싱 제품의 가용성 등이 촉진하고 있습니다.

차세대 시퀀스 기술의 진보를 향후 수년간 NGS 기반 RNA 시퀀싱 시장의 성장을 촉진하는 주요 이유의 하나로 식별하고 있습니다. 또한 유전자 시퀀스의 비용 삭감과 바이오인포매틱스 및 클라우드 기반·소프트웨어 프로그램의 개발이 시장의 큰 수요로 연결됩니다.

목차

제1장 개요

• 시장 개요

제2장 시장 구도

• 시장 에코시스템
• 시장의 특징
• 밸류체인 분석

제3장 시장 규모의 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 NGS 기반 RNA 시퀀싱 시장(2018-2022년)
• 최종사용자별 분석(2018-2022년)
• 기술별 분석(2018-2022년)
• 지역별 분석(2018-2022년)
• 국가별 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 최종사용자별 시장 세분화

• 시장 세분화
• 비교 : 최종사용자별
• 학술연구 센터 : 시장 규모와 예측(2023-2028년)
• 임상 연구 : 시장 규모와 예측(2023-2028년)
• 제약 기업 : 시장 규모와 예측(2023-2028년)
• 병원 : 시장 규모와 예측(2023-2028년)
• 최종사용자별 시장 기회

제7장 기술별 시장 세분화

• 시장 세분화
• 비교 : 기술별
• 합성에 의한 시퀀싱 : 시장 규모와 예측(2023-2028년)
• 이온 반도체 시퀀싱 : 시장 규모와 예측(2023-2028년)
• 단일 분자 실시간 시퀀싱 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 기술별 시장 기회

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계의 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 싱가포르 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 지역별 시장 기회

제10장 촉진요인·과제·기회·억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장의 기회·억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Agilent Technologies Inc.
• Azenta Inc.
• BGI Genomics Co. Ltd.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Hamilton Co.
• Illumina Inc.
• Pacific Biosciences of California Inc.
• Perkin Elmer Inc.
• Psomagen Inc.
• QIAGEN NV
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Zymo Research Corp.

제13장 부록

영문목차

NGS-based RNA-seq Market 2024-2028

The NGS-based RNA-seq market is forecasted to grow by USD 6659 mn during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.

Technavio's NGS-based RNA-seq market is segmented as below:

By End-user

• Acamedic and research centers
• Clinical research
• Pharma companies
• Hospitals

By Technology

• Sequencing by synthesis
• Ion semiconductor sequencing
• Single-molecule real-time sequencing
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

• NGS-based RNA-seq market sizing
• NGS-based RNA-seq market forecast
• NGS-based RNA-seq market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp.. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global NGS-Based RNA-Seq Market 2018 - 2022
  • Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
• 4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Technology segment analysis 2018 - 2022
  • Historic Market Size - Technology Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 6.3 Acamedic and research centers - Market size and forecast 2023-2028
  • Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
• 6.4 Clinical research - Market size and forecast 2023-2028
  • Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Chart on Clinical research - Year-over-year growth 2023-2028 (%)
  • Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
• 6.5 Pharma companies - Market size and forecast 2023-2028
  • Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
• 6.6 Hospitals - Market size and forecast 2023-2028
  • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
  • Chart on Technology - Market share 2023-2028 (%)
  • Data Table on Technology - Market share 2023-2028 (%)
• 7.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 7.3 Sequencing by synthesis - Market size and forecast 2023-2028
  • Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
• 7.4 Ion semiconductor sequencing - Market size and forecast 2023-2028
  • Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
• 7.5 Single-molecule real-time sequencing - Market size and forecast 2023-2028
  • Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 Singapore - Market size and forecast 2023-2028
  • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
• 12.4 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key news
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
• 12.5 BGI Genomics Co. Ltd.
  • BGI Genomics Co. Ltd. - Overview
  • BGI Genomics Co. Ltd. - Product / Service
  • BGI Genomics Co. Ltd. - Key offerings
• 12.6 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key news
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Hamilton Co.
  • Hamilton Co. - Overview
  • Hamilton Co. - Product / Service
  • Hamilton Co. - Key offerings
• 12.9 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
• 12.10 Pacific Biosciences of California Inc.
  • Pacific Biosciences of California Inc. - Overview
  • Pacific Biosciences of California Inc. - Product / Service
  • Pacific Biosciences of California Inc. - Key offerings
• 12.11 Perkin Elmer Inc.
  • Perkin Elmer Inc. - Overview
  • Perkin Elmer Inc. - Business segments
  • Perkin Elmer Inc. - Key news
  • Perkin Elmer Inc. - Key offerings
  • Perkin Elmer Inc. - Segment focus
• 12.12 Psomagen Inc.
  • Psomagen Inc. - Overview
  • Psomagen Inc. - Product / Service
  • Psomagen Inc. - Key offerings
• 12.13 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
• 12.14 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
• 12.15 Tecan Trading AG
  • Tecan Trading AG - Overview
  • Tecan Trading AG - Business segments
  • Tecan Trading AG - Key news
  • Tecan Trading AG - Key offerings
  • Tecan Trading AG - Segment focus
• 12.16 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Zymo Research Corp.
  • Zymo Research Corp. - Overview
  • Zymo Research Corp. - Product / Service
  • Zymo Research Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations